Myriad Applauds New ACOG Guidelines For Hereditary Breast And Ovarian Cancer

News — By on March 26, 2009 at 12:00 am

Myriad Genetics, Inc. (NASDAQ: MYGN) announced its support of The American College of Obstetricians and Gynecologists (ACOG) Practice Bulletin Number 103, dated April 2009, which sets forth ACOG’s clinical management guidelines for obstetricians and gynecologists.

Please read the complete article and let us know what you think below.

Leave a Reply


Leave a Trackback